Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 30, 2025 • 10:51 AM ET

Date/Time Source News Release
07/18/2025 09:15 AM EDT GlobeNewswire Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval
07/02/2025 08:05 AM EDT GlobeNewswire Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
07/01/2025 07:00 AM EDT GlobeNewswire Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index
06/18/2025 07:00 AM EDT GlobeNewswire Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa(TM) Fentanyl Abuse Deterrent Fentanyl Patch
06/09/2025 07:30 AM EDT GlobeNewswire Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology
06/03/2025 08:00 AM EDT GlobeNewswire Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
06/02/2025 08:00 AM EDT GlobeNewswire Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
05/27/2025 08:00 AM EDT GlobeNewswire IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.
04/30/2025 07:30 AM EDT GlobeNewswire Nutriband CEO Publishes Letter to Shareholders
04/11/2025 07:00 AM EDT GlobeNewswire Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
Page

Additional News

As of July 30, 2025 • 10:51 AM ET

Date/Time Source News Release
07/25/2025 10:30 AM EDT BioMedWire BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB): Innovation Meets Science Through Scalable Platform  
07/18/2025 10:25 AM EDT BioMedWire BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Sets Key Dates for 25% Preferred Stock Dividend
07/11/2025 02:35 PM EDT InvestorWire InvestorNewsBreaks - Rare Biotech Story: Nutriband Inc. (NASDAQ: NTRB) Founder Shares Vision in Smart Money Circle Podcast
07/03/2025 11:20 AM EDT BioMedWire Nutriband Inc. (NASDAQ: NTRB) Added to Four Key Indexes, Rethinking Opioid Safety in a Time of Crisis
07/02/2025 09:48 AM EDT InvestorWire InvestorNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Declares 25% Preferred Stock Dividend Linked to AVERSA Fentanyl Approval 
07/01/2025 09:45 AM EDT BioMedWire BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Added to Four Russell Indexes in 2025 Reconstitution
07/01/2025 07:31 AM EDT SeekingAlpha Nutriband added to the Russell Microcap index, Russell Microcap Growth index, Russell 3000E index and Russell 3000E growth index
06/23/2025 09:05 AM EDT BioMedWire BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Price Target Raised to $15 Following AVERSA Fentanyl Manufacturing Milestone
06/20/2025 09:50 AM EDT BioMedWire Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation
06/18/2025 09:25 AM EDT BioMedWire BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale
Page